{"organizations": [], "uuid": "f9568f91f3095951dff55dd362feb0fb6ca64db9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novartis-enters-agreement-to-acqui/brief-novartis-enters-agreement-to-acquire-avexis-for-8-7-bln-idUSASO000317", "country": "US", "domain_rank": 408, "title": "BRIEF-Novartis Enters Agreement To Acquire AveXis For $8.7 Bln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-09T07:50:00.000+03:00", "replies_count": 0, "uuid": "f9568f91f3095951dff55dd362feb0fb6ca64db9"}, "author": "", "url": "https://www.reuters.com/article/brief-novartis-enters-agreement-to-acqui/brief-novartis-enters-agreement-to-acquire-avexis-for-8-7-bln-idUSASO000317", "ord_in_thread": 0, "title": "BRIEF-Novartis Enters Agreement To Acquire AveXis For $8.7 Bln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "novartis ag", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "novartis", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "novartis ag", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9, 2018 / 4:54 AM / Updated 11 minutes ago BRIEF-Novartis Enters Agreement To Acquire AveXis For $8.7 Bln Reuters Staff 1 Min Read \nApril 9 (Reuters) - Novartis AG: \n* NOVARTIS ENTERS AGREEMENT TO ACQUIRE AVEXIS INC. FOR USD 8.7 BN TO TRANSFORM CARE IN SMA AND EXPAND POSITION AS A GENE THERAPY AND NEUROSCIENCE LEADER \n* NOVARTIS ENTERS AGREEMENT TO ACQUIRE AVEXIS INC. FOR USD 8.7 BN TO TRANSFORM CARE IN SMA AND EXPAND POSITION AS A GENE THERAPY AND NEUROSCIENCE LEADER \n* NOVARTIS AG- ‚ÄçASSUMING MID 2018 COMPLETION, ACQUISITION IMPACT WOULD BE SLIGHTLY NEGATIVE TO CORE OPERATING INCOME IN 2018 AND 2019 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-09T07:50:00.000+03:00", "crawled": "2018-04-09T08:11:35.018+03:00", "highlightTitle": ""}